Skip to content
B
BiotechEdge

Horizon Therapeutics + Amgen

closed

$HZNP acquired by Amgen for $27.8B

Deal Summary

Deal Value
$27.8B
Price/Share
$116.5
Announced
Dec 12, 2022
Closed
Oct 6, 2023
← All biotech acquisitions